DEF 14A: Biote Corp. Announces Annual Meeting of Stockholders to be Held Virtually on May 21, 2024

Biote Corp. will hold its annual meeting of stockholders virtually on May 21, 2024, to elect directors and ratify the appointment of Deloitte & Touche LLP as its independent accounting firm.

Summary

• Biote Corp. is holding its 2024 annual meeting of stockholders virtually on May 21, 2024.
• The meeting will include the election of three Class II directors (Steven J. Heyer, S. Mark Cone, and Debra L. Morris) to serve until the 2027 annual meeting.
• Stockholders will also vote to ratify the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
• The record date for determining stockholders eligible to vote is April 1, 2024.
• The company's principal executive office is located at 1875 W. Walnut Hill Ln, #100, Irving, TX 75038.
• Stockholders can access the proxy materials and annual report at www.proxydocs.com/BTMD.

Sentiment

Score: 7

Explanation: The document is a standard corporate communication, presenting factual information in a neutral tone. It is neither overly positive nor negative, reflecting routine corporate governance procedures.

Positives

• The virtual format of the annual meeting is expected to increase stockholder attendance and participation while reducing costs.
• The board recommends voting 'For' all director nominees and the ratification of the accounting firm, indicating confidence in these selections.

Future Outlook

The document outlines the procedures for the upcoming annual meeting and provides information for stockholders to make informed decisions on the proposals presented.

Industry Context

This is a standard proxy statement related to corporate governance and shareholder voting rights, common for publicly traded companies.

Management Changes

Related Party Transactions

• Mandy Cotten, the daughter of Dr. Gary S. Donovitz, was employed by BioTE Medical as a Clinic Director from September 1, 2015 to June 14, 2022.
• Lani Hammonds Donovitz, the former wife of Dr. Gary S. Donovitz, was employed by BioTE Medical from January 1, 2021 through April 30, 2021, as Director, Business Development Research.
• BioTE Medical and Dr. Gary S. Donovitz, MD, entered into a Founder Advisory Agreement, effective as of the Closing.
• BioTE Medical entered into an Independent Contractor Agreement with Lani D. Consulting, a company affiliated with Lani Hammonds Donovitz, the wife of Dr. Gary S. Donovitz, MD.

Stakeholder Impact

• The outcome of the director elections and the ratification of the accounting firm will impact shareholders.
• Executive compensation and related party transactions are disclosed, affecting transparency for stakeholders.

Next Steps

• Stockholders are encouraged to vote on the proposals before the annual meeting.
• Stockholders can attend the virtual annual meeting on May 21, 2024.

Key Dates

Keywords

annual meeting, proxy statement, directors, Deloitte & Touche LLP, stockholders, voting, governance, Biote Corp